snc-logo

Start-Up Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Smartlists
My Saved Searches
Inbox
About Us
Glossary

Add companies to smartlist

45 companies were selected
Add smartlist note (optional)

Create new smartlist

Smartlist name*
Smartlist must have a valid name.
Description (optional)
Hey #USER_FULLNAME#!
Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

The invitation to claim the profile was originally sent to

or  

Hey #USER_FULLNAME#!
Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

Suggest Edits

Let us know what you think is inaccurate or missing.
We will check it out and update the profile if needed.

Claim Profile

Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

Already have an account? Login

Nice work!

To continue the registration process,
please check your email inbox at email@email.com
to validate your account.

We'll see you back here soon. :-)

Do not forget to check your spam folder

Didn’t get the email? Resend email or Contact us

Reset password
Don't have an account? Sign up

Check your mailbox

We sent you an email with further instructions to
email@email.com

Do not forget to check your spam folder

Didn’t get the email? Resend email or Contact us

Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

Save Search

Search must have a valid name.
Search Was Saved

Rename Search

Search must have a valid name.
Search Was Saved
Delete Saved Search Confirmation
search will be permanently removed from Finder.
Home > Companies > Teva Pharmaceuticals
Claimed by owner Last Update 21.5.2023 Suggest Edits Claim Profile
Claimed by owner
Teva Pharmaceuticals logo

Teva Pharmaceuticals

Generic and Specialty Pharmaceuticals

Non Visible
Public on TASE Jan, 1951
Public on NYSE Jan, 1982
Teva Pharmaceuticals
About
Lifecycle
News
Gallery
en.globes.co.ilMay 18, 2023
Teva targets growth through innovation
www.calcalistech.comMay 10, 2023
Teva profit plummets, stock slides | CTech
www.globes.co.ilDec 11, 2022
גלובס זירת העסקים של ישראל
www.calcalistech.comNov 22, 2022
Teva names Richard Francis as new CEO after Kåre Schultz departure | CTech
www.businesswire.comOct 25, 2022
Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved Communities - Awarded Funding from Teva Pharmaceuticals, Direct Relief and NAFC
www.businesswire.comOct 6, 2022
Teva Announces Largest-Ever Trial to Collect Information from Patients and Physicians About TD, its Impact and Progression Over Time, and Evaluate Treatment-Related Outcomes
www.worldpharmatoday.comJun 13, 2022
Teva Post Lupin Deal To Launch Austedo Generic Rival In 2033
en.globes.co.ilMar 22, 2022
Teva agrees opioid settlement with Rhode Island
en.globes.co.ilFeb 27, 2022
Teva announces debt recycling measures
en.globes.co.ilDec 27, 2021
Teva and Tikun Olam-Cannbit sign medical cannabis deal
en.globes.co.ilNov 2, 2021
Teva wins opioids case in California court
en.globes.co.ilOct 11, 2021
Teva to lay off 200 in Israel
en.globes.co.ilDec 6, 2020
Teva readying to distribute Covid-19 vaccine in Israel
www.businesswire.comOct 7, 2020
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfrm) Injection Published in Headache
www.marketwatch.comSep 21, 2020
https://www.marketwatch.com/press-release/teva-launches-two-digital-inhalers-in-the-us-airduo-digihaler-fluticasone-propionate-and-salmeterol-inhalation-powder-and-armonair-digihaler-fluticasone-propionate-inhalation-powder-2020-09-21?siteid=bigcharts&dist=bigcharts&tesla=yer%C2%AE-fluticasone-propionate-Inhalation-Powder
www.calcalistech.comSep 13, 2020
Teva is recruiting Israeli academia to help produce its next breakthrough drug
en.globes.co.ilAug 23, 2020
Teva announces 350 layoffs at Negev plant
www.timesofisrael.comAug 5, 2020
Teva joins forces with Icelandic firm to gain edge on biosimilars
en.globes.co.ilJul 30, 2020
Teva scales down Japanese operations
www.biospace.comJul 13, 2020
Teva Announces Availability of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma and COPD BioSpace
en.globes.co.ilMay 18, 2020
Teva's Austedo wins marketing approval for China
en.globes.co.ilMay 4, 2020
Teva launches Rituxan biosimilar for Rheumatoid Arthritis
en.globes.co.ilApr 27, 2020
Teva launches auto-injectable Ajovy in US
en.globes.co.ilApr 20, 2020
Teva Israel CEO quits to head medical cannabis co Cannbit
en.globes.co.ilApr 1, 2020
US court upholds validity of Teva's Ajovy patents
en.globes.co.ilMar 31, 2020
Teva drugs approved for emergency Covid-19 trials
www.jpost.comMar 20, 2020
https://www.jpost.com/HEALTH-SCIENCE/Teva-donates-potential-coronavirus-treatment-to-hospitals-across-the-US-621688
en.globes.co.ilFeb 26, 2020
Teva asks FDA to define Copaxone as biologics drug
en.globes.co.ilFeb 24, 2020
Teva digital asthma inhaler wins FDA nod
en.globes.co.ilFeb 19, 2020
Teva CEO: We have to launch new products
www.calcalistech.comFeb 16, 2020
Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns
www.calcalistech.comJan 29, 2020
Teva Receives FDA Approval for Migraine Autoinjector
en.globes.co.ilJan 16, 2020
Teva must return non-MS Copaxone rights to Proneuron
en.globes.co.ilJan 14, 2020
Teva looks to China
en.globes.co.ilJan 7, 2020
Teva seeks blockbuster drug to succeed Copaxone
en.globes.co.ilJan 6, 2020
Teva to pay $54m to settle Copaxone bribery case in US
en.globes.co.ilNov 25, 2019
Teva teams with Weizmann Institute, Tel Aviv U
www.calcalistech.comNov 17, 2019
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing
www.calcalistech.comOct 22, 2019
Teva Announces $23.25 Billion Opioid Abuse Settlement Agreement
www.calcalistech.comOct 16, 2019
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says
en.globes.co.ilOct 2, 2019
Teva EVP global operations steps down
en.globes.co.ilSep 17, 2019
Teva enters Israel's cannabis market
en.globes.co.ilSep 10, 2019
Teva to merge communications into HR
www.businesswire.comAug 7, 2019
Teva Announces CFO Leadership Transition
en.globes.co.ilAug 1, 2019
Teva to sell Oncotest to Rhenium
www.calcalistech.comJul 30, 2019
Teva to Pay California $69 Million in Narcolepsy Drug Settlement
www.biospace.comJul 15, 2019
Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder BioSpace
www.businesswire.comJul 11, 2019
Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Campus
www.biospectrumasia.comJun 20, 2019
Teva announces launch of a generic version of Tracleer® in US
www.calcalistech.comMay 27, 2019
Teva Reaches $85 Million Settlement in Oklahoma Opioid Damages Suit
www.jpost.comMay 13, 2019
https://www.jpost.com/Israel-News/Teva-rejects-wrongdoing-in-drug-price-fixing-lawsuit-589455
en.globes.co.ilMay 3, 2019
Teva CEO unsure about 2020 growth
www.calcalistech.comMay 2, 2019
Teva Completes $47.5 Million Sale of Northern Israeli Plant to Private Equity Fund FIMI
en.globes.co.ilApr 23, 2019
Teva abandons fremanezumab cluster headache trial
en.globes.co.ilApr 22, 2019
Teva launches generic overactive bladder treatment
en.globes.co.ilApr 21, 2019
FDA approves Teva opioid antidote nasal spray
en.globes.co.ilApr 14, 2019
Teva rebrands to raise consumer awareness
www.calcalistech.comApr 1, 2019
Teva Makes Headway in European Copaxone Patent Case
en.globes.co.ilApr 1, 2019
Teva migraine drug Ajovy wins European approval
en.globes.co.ilMar 24, 2019
Teva launches generic iron overload treatment
en.globes.co.ilFeb 18, 2019
Teva reconnecting to Israel's startup ecosystem
en.globes.co.ilFeb 10, 2019
FIMI buys Teva plant in Kiryat Shmona
en.globes.co.ilNov 5, 2018
Morgan Stanley upgrades Teva
www.haaretz.comMar 19, 2018
Teva in crisis: Group of investors may offer to buy part of Teva's Israel operations
www.marketwatch.comMar 19, 2018
http://www.marketwatch.com/story/teva-reinforces-leadership-position-in-respiratory-with-acquisition-of-gecko-health-innovations-2015-09-25
www.globes.co.ilMar 19, 2018
Teva buys Mexican co Rimsa for $2.3b
www.axios.comFeb 15, 2018
Buffett buys $358 million stake in Teva
www.globes.co.ilJun 22, 2017
Teva loses $235m patent trial to GSK
www.globes.co.ilSep 20, 2016
Teva buys rights to chronic pain drug for $250m
www.globes.co.ilAug 3, 2016
Teva completes acquisition of Actavis Generics
www.tevapharm.comJul 25, 2016
http://www.tevapharm.com/news/teva_to_acquire_allergan_generics_for_40_5_billion_creating_a_transformative_generics_and_specialty_company_well_positioned_to_win_in_global_healthcare_07_15.aspx
www.globes.co.ilJan 26, 2016
Teva: 35% of senior management are women
www.globes.co.ilJan 5, 2016
Teva launches generic contraceptive pill
www.globes.co.ilDec 15, 2015
Teva invests $30m in US co Wave Life Sciences
www.globes.co.ilSep 25, 2015
Teva acquires Gecko Health Innovations
www.globes.co.ilAug 3, 2015
Teva buys 51% stake in US co Immuneering for $60m
www.globes.co.ilJul 27, 2015
Teva buying Allergan Generics for $40.5b
www.globes.co.ilJun 19, 2015
Teva completes acquisition of 4.6% Mylan stake
www.globes.co.ilJun 1, 2015
Teva launches generic osteoporosis drug
www.globes.co.ilMar 30, 2015
Teva to acquire Auspex for $3.2b
www.globes.co.ilMar 29, 2015
Teva close to major acquisition - report
www.globes.co.ilJan 3, 2015
Teva raises extra $658m in underwriters' options

About

Teva is a global pharmaceutical company that develops, produces, and markets generic drugs, specialty pharmaceuticals, and active pharmaceutical ingredients.

Headquartered in Israel, Teva has a product portfolio of more than 3,600 medicines and produces approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. Teva is ranked among the leading pharmaceutical companies in the world and is active in 60 countries, with approximately 43,000 employees worldwide.

Founded

Business models

B2C, B2B

Employees

Product stage

Primary Sector

Life Sciences & HealthTech

Products

Ajovy, Copaxone, EXJADE, Narcan, VESIcare, Austedo

Geographic markets

Global

Funding

Total Funding

Undisclosed

Market Cap

$9.82B

Last Funding

Undisclosed

Funding Stage

Total Rounds

2

Investors

0

News

  (82)
en.globes.co.ilMay 18, 2023
Teva targets growth through innovation
www.calcalistech.comMay 10, 2023
Teva profit plummets, stock slides | CTech
www.globes.co.ilDec 11, 2022
גלובס זירת העסקים של ישראל
www.calcalistech.comNov 22, 2022
Teva names Richard Francis as new CEO after Kåre Schultz departure | CTech
www.businesswire.comOct 25, 2022
Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved Communities - Awarded Funding from Teva Pharmaceuticals, Direct Relief and NAFC
www.businesswire.comOct 6, 2022
Teva Announces Largest-Ever Trial to Collect Information from Patients and Physicians About TD, its Impact and Progression Over Time, and Evaluate Treatment-Related Outcomes
www.worldpharmatoday.comJun 13, 2022
Teva Post Lupin Deal To Launch Austedo Generic Rival In 2033
en.globes.co.ilMar 22, 2022
Teva agrees opioid settlement with Rhode Island
en.globes.co.ilFeb 27, 2022
Teva announces debt recycling measures
en.globes.co.ilDec 27, 2021
Teva and Tikun Olam-Cannbit sign medical cannabis deal
en.globes.co.ilNov 2, 2021
Teva wins opioids case in California court
en.globes.co.ilOct 11, 2021
Teva to lay off 200 in Israel
en.globes.co.ilDec 6, 2020
Teva readying to distribute Covid-19 vaccine in Israel
www.businesswire.comOct 7, 2020
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfrm) Injection Published in Headache
www.marketwatch.comSep 21, 2020
https://www.marketwatch.com/press-release/teva-launches-two-digital-inhalers-in-the-us-airduo-digihaler-fluticasone-propionate-and-salmeterol-inhalation-powder-and-armonair-digihaler-fluticasone-propionate-inhalation-powder-2020-09-21?siteid=bigcharts&dist=bigcharts&tesla=yer%C2%AE-fluticasone-propionate-Inhalation-Powder
www.calcalistech.comSep 13, 2020
Teva is recruiting Israeli academia to help produce its next breakthrough drug
en.globes.co.ilAug 23, 2020
Teva announces 350 layoffs at Negev plant
www.timesofisrael.comAug 5, 2020
Teva joins forces with Icelandic firm to gain edge on biosimilars
en.globes.co.ilJul 30, 2020
Teva scales down Japanese operations
www.biospace.comJul 13, 2020
Teva Announces Availability of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma and COPD BioSpace
en.globes.co.ilMay 18, 2020
Teva's Austedo wins marketing approval for China
en.globes.co.ilMay 4, 2020
Teva launches Rituxan biosimilar for Rheumatoid Arthritis
en.globes.co.ilApr 27, 2020
Teva launches auto-injectable Ajovy in US
en.globes.co.ilApr 20, 2020
Teva Israel CEO quits to head medical cannabis co Cannbit
en.globes.co.ilApr 1, 2020
US court upholds validity of Teva's Ajovy patents
en.globes.co.ilMar 31, 2020
Teva drugs approved for emergency Covid-19 trials
www.jpost.comMar 20, 2020
https://www.jpost.com/HEALTH-SCIENCE/Teva-donates-potential-coronavirus-treatment-to-hospitals-across-the-US-621688
en.globes.co.ilFeb 26, 2020
Teva asks FDA to define Copaxone as biologics drug
en.globes.co.ilFeb 24, 2020
Teva digital asthma inhaler wins FDA nod
en.globes.co.ilFeb 19, 2020
Teva CEO: We have to launch new products
www.calcalistech.comFeb 16, 2020
Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns
www.calcalistech.comJan 29, 2020
Teva Receives FDA Approval for Migraine Autoinjector
en.globes.co.ilJan 16, 2020
Teva must return non-MS Copaxone rights to Proneuron
en.globes.co.ilJan 14, 2020
Teva looks to China
en.globes.co.ilJan 7, 2020
Teva seeks blockbuster drug to succeed Copaxone
en.globes.co.ilJan 6, 2020
Teva to pay $54m to settle Copaxone bribery case in US
en.globes.co.ilNov 25, 2019
Teva teams with Weizmann Institute, Tel Aviv U
www.calcalistech.comNov 17, 2019
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing
www.calcalistech.comOct 22, 2019
Teva Announces $23.25 Billion Opioid Abuse Settlement Agreement
www.calcalistech.comOct 16, 2019
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says
en.globes.co.ilOct 2, 2019
Teva EVP global operations steps down
en.globes.co.ilSep 17, 2019
Teva enters Israel's cannabis market
en.globes.co.ilSep 10, 2019
Teva to merge communications into HR
www.businesswire.comAug 7, 2019
Teva Announces CFO Leadership Transition
en.globes.co.ilAug 1, 2019
Teva to sell Oncotest to Rhenium
www.calcalistech.comJul 30, 2019
Teva to Pay California $69 Million in Narcolepsy Drug Settlement
www.biospace.comJul 15, 2019
Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder BioSpace
www.businesswire.comJul 11, 2019
Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Campus
www.biospectrumasia.comJun 20, 2019
Teva announces launch of a generic version of Tracleer® in US
www.calcalistech.comMay 27, 2019
Teva Reaches $85 Million Settlement in Oklahoma Opioid Damages Suit
www.jpost.comMay 13, 2019
https://www.jpost.com/Israel-News/Teva-rejects-wrongdoing-in-drug-price-fixing-lawsuit-589455
en.globes.co.ilMay 3, 2019
Teva CEO unsure about 2020 growth
www.calcalistech.comMay 2, 2019
Teva Completes $47.5 Million Sale of Northern Israeli Plant to Private Equity Fund FIMI
en.globes.co.ilApr 23, 2019
Teva abandons fremanezumab cluster headache trial
en.globes.co.ilApr 22, 2019
Teva launches generic overactive bladder treatment
en.globes.co.ilApr 21, 2019
FDA approves Teva opioid antidote nasal spray
en.globes.co.ilApr 14, 2019
Teva rebrands to raise consumer awareness
www.calcalistech.comApr 1, 2019
Teva Makes Headway in European Copaxone Patent Case
en.globes.co.ilApr 1, 2019
Teva migraine drug Ajovy wins European approval
en.globes.co.ilMar 24, 2019
Teva launches generic iron overload treatment
en.globes.co.ilFeb 18, 2019
Teva reconnecting to Israel's startup ecosystem
en.globes.co.ilFeb 10, 2019
FIMI buys Teva plant in Kiryat Shmona
en.globes.co.ilNov 5, 2018
Morgan Stanley upgrades Teva
www.haaretz.comMar 19, 2018
Teva in crisis: Group of investors may offer to buy part of Teva's Israel operations
www.marketwatch.comMar 19, 2018
http://www.marketwatch.com/story/teva-reinforces-leadership-position-in-respiratory-with-acquisition-of-gecko-health-innovations-2015-09-25
www.globes.co.ilMar 19, 2018
Teva buys Mexican co Rimsa for $2.3b
www.axios.comFeb 15, 2018
Buffett buys $358 million stake in Teva
www.globes.co.ilJun 22, 2017
Teva loses $235m patent trial to GSK
www.globes.co.ilSep 20, 2016
Teva buys rights to chronic pain drug for $250m
www.globes.co.ilAug 3, 2016
Teva completes acquisition of Actavis Generics
www.tevapharm.comJul 25, 2016
http://www.tevapharm.com/news/teva_to_acquire_allergan_generics_for_40_5_billion_creating_a_transformative_generics_and_specialty_company_well_positioned_to_win_in_global_healthcare_07_15.aspx
www.globes.co.ilJan 26, 2016
Teva: 35% of senior management are women
www.globes.co.ilJan 5, 2016
Teva launches generic contraceptive pill
www.globes.co.ilDec 15, 2015
Teva invests $30m in US co Wave Life Sciences
www.globes.co.ilSep 25, 2015
Teva acquires Gecko Health Innovations
www.globes.co.ilAug 3, 2015
Teva buys 51% stake in US co Immuneering for $60m
www.globes.co.ilJul 27, 2015
Teva buying Allergan Generics for $40.5b
www.globes.co.ilJun 19, 2015
Teva completes acquisition of 4.6% Mylan stake
www.globes.co.ilJun 1, 2015
Teva launches generic osteoporosis drug
www.globes.co.ilMar 30, 2015
Teva to acquire Auspex for $3.2b
www.globes.co.ilMar 29, 2015
Teva close to major acquisition - report
www.globes.co.ilJan 3, 2015
Teva raises extra $658m in underwriters' options

The Team

(8)
KS
Kare Schultz
President & CEO
Connect
DMS
David M. Stark
Executive Vice President, Chief Legal Officer
Connect
RD
Richard Daniell
EVP - Head of Europe Commercial
Connect
DSD
Dr. Sven Dethlefs
EVP Global Marketing & Portfolio
Connect
ED
Eric Drap
EVP Teva Global Operations
Connect
DHF
Dr. Hafrun Fridriksdottir
EVP, President of Global Generics R&D
MS
Mark Sabag
Group Executive Vice President, Human Resources
Connect
LQ
Lori Queisser
Sr. Vice President & Global Compliance Officer
Connect

Connect with

What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300

Sending invitation...

Company Lifecycle

Event View
Timeline View

Public Offerings & Exits

Initial Public Offering EXIT
Undisclosed
Jan 1951
Stock Exchange
TASE logo
TASE
Valuation Undisclosed
Undisclosed
Public Offering
Undisclosed
Jan 1982
Stock Exchange
NYSE logo
NYSE
Valuation Undisclosed
Undisclosed

Locations

Israel

Basel Street 5, Petah Tiqwa, Israel
Kiryat HaMada Street 20, Jerusalem, Israel

Offices Abroad

1090 Horsham Road, North Wales, PA, USA
Swensweg 5, Haarlem, Netherlands
Laarstraat 16, Antwerp, Belgium
Aston Lane North, Runcorn, UK
Debrecen, Pallagi t 13, Hungary

Sector

Life Sciences & HealthTech
Pharma & Biomedicine
Medical Cannabis
Discovery & Development
Biomaterials

Core Technology

Biologicals

Target Customer

Healthcare & Life Sciences
Life Sciences
Cosmetics
Pharmaceuticals
Biotechnology

Tags

(15)

Locations

Israel

Basel Street 5, Petah Tiqwa, Israel
Kiryat HaMada Street 20, Jerusalem, Israel

Offices Abroad

1090 Horsham Road, North Wales, PA, USA
Swensweg 5, Haarlem, Netherlands
Laarstraat 16, Antwerp, Belgium
Aston Lane North, Runcorn, UK
Debrecen, Pallagi t 13, Hungary

Notes

Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
  • Get unlimited search results
  • Save to custom lists - Smartlists
  • Get notified with news and updates
  • Connect with people
And much more...
I already have access,
I already have access,